Bowen Hanes & CO Inc Edwards Lifesciences Corp Transaction History

Bowen Hanes & CO Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$81.41 - $94.33 $28.9 Million - $33.5 Million	355,145 New	355,145 $33.5 Million
Q4 2022 Feb 09, 2023	SELL	$68.3 - $87.44 $1.7 Million - $2.17 Million	-24,820 Reduced 84.51%	4,550 $339,000
Q3 2022 Nov 14, 2022	SELL	$82.37 - $107.29 $21,416 - $27,895	-260 Reduced 0.88%	29,370 $2.43 Million
Q2 2022 Aug 12, 2022	SELL	$86.5 - $128.27 $22.1 Million - $32.7 Million	-255,290 Reduced 89.6%	29,630 $2.82 Million
Q1 2022 May 12, 2022	BUY	$101.96 - $128.34 $4.83 Million - $6.08 Million	47,390 Added 19.95%	284,920 $33.5 Million
Q4 2021 Feb 11, 2022	BUY	$106.37 - $130.68 $25.3 Million - $31 Million	237,530 New	237,530 $30.8 Million

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Bowen Hanes & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Bowen Hanes & CO Inc with notifications on news.